Map of Pancreatica Walks and Runs

Monthly Archives: March 2014

Clinical trial of Combination of Targeted Anti-Kras Therapy for Pancreatic Cancer

Dutch and primarily other European researchers are about to begin a human clinical trial involving a regimen of two relatively new targeted therapies (afatinib plus selumetinib) for the treatment of pancreatic cancer.  Afatinib is known as Gilotrif in the U.S., and is produced by the family-owned global but German-headquartered Boehringer Ingelheim Pharmaceuticals firm.  Selumetinib is […]

Share Button

Glycoprotein Biomarkers for Malignancy in Pancreatic Cysts

We speak of pancreatic cancer as if it is one thing, but there are many kinds of pancreatic cancer; one classification had this number at 17.  A frequent anatomic / physiologic action of the pancreas is that it tends to produce cysts (and sometimes even “pseudocysts” – pockets of fluid often seen as a result […]

Share Button

The Relationship Between Diabetes and Pancreatic Cancer

“It’s complicated.”  But why should pancreatic cancer be any less convoluted than other aspects of the pancreas?  The origin of the embryologic pancreas develops from TWO buds off of the foregut – that EACH “typically” moves and develops, eventually merging to form what we know as the pancreas.  This somewhat individualistic merging process alone produces […]

Share Button